BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20640495)

  • 1. Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin.
    Ye Y; Long B; Qian J; Perez-Polo JR; Birnbaum Y
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):391-9. PubMed ID: 20640495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions.
    Ye Y; Perez-Polo JR; Birnbaum Y
    Ann N Y Acad Sci; 2010 Oct; 1207():76-82. PubMed ID: 20955429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
    Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size.
    Ye Y; Keyes KT; Zhang CF; Perez-Polo JR; Lin Y; Birnbaum Y
    Cardiovasc Drugs Ther; 2010 Apr; 24(2):107-20. PubMed ID: 20379769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.
    Ye Y; Lin Y; Perez-Polo R; Huang MH; Hughes MG; McAdoo DJ; Manickavasagam S; Uretsky BF; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H813-8. PubMed ID: 17416607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.
    Li XD; Yang YJ; Geng YJ; Zhao JL; Zhang HT; Cheng YT; Wu YL
    Acta Pharmacol Sin; 2012 Jul; 33(7):879-87. PubMed ID: 22659627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect.
    Nanhwan MK; Ling S; Kodakandla M; Nylander S; Ye Y; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2078-85. PubMed ID: 25012137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolvin E1 protects the rat heart against reperfusion injury.
    Keyes KT; Ye Y; Lin Y; Zhang C; Perez-Polo JR; Gjorstrup P; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H153-64. PubMed ID: 20435846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress.
    Andreadou I; Farmakis D; Prokovas E; Sigala F; Zoga A; Spyridaki K; Papalois A; Papapetropoulos A; Anastasiou-Nana M; Kremastinos DT; Iliodromitis EK
    Cardiovasc Res; 2012 Jun; 94(3):501-9. PubMed ID: 22411971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
    Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.
    Wolfrum S; Dendorfer A; Schutt M; Weidtmann B; Heep A; Tempel K; Klein HH; Dominiak P; Richardt G
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):348-55. PubMed ID: 15475833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels.
    Tavackoli S; Ashitkov T; Hu ZY; Motamedi M; Uretsky BF; Birnbaum Y
    Coron Artery Dis; 2004 Feb; 15(1):53-8. PubMed ID: 15201621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.
    Kocsis GF; Pipis J; Fekete V; Kovács-Simon A; Odendaal L; Molnár E; Giricz Z; Janáky T; van Rooyen J; Csont T; Ferdinandy P
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2406-9. PubMed ID: 18359895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat.
    Wayman NS; Ellis BL; Thiemermann C
    Med Sci Monit; 2003 May; 9(5):BR155-9. PubMed ID: 12761443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat.
    Ye Y; Abu Said GH; Lin Y; Manickavasagam S; Hughes MG; McAdoo DJ; Perez-Polo RJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):275-82. PubMed ID: 18327703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.
    Manickavasagam S; Ye Y; Lin Y; Perez-Polo RJ; Huang MH; Lui CY; Hughes MG; McAdoo DJ; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):321-30. PubMed ID: 17620005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
    Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries.
    Rossoni LV; Wareing M; Wenceslau CF; Al-Abri M; Cobb C; Austin C
    Clin Sci (Lond); 2011 Nov; 121(10):449-58. PubMed ID: 21671887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation.
    Merla R; Ye Y; Lin Y; Manickavasagam S; Huang MH; Perez-Polo RJ; Uretsky BF; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1918-28. PubMed ID: 17616749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.